| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |